Keybanc analyst Thomas Blakey maintains Cloudflare (NYSE:NET) with a Overweight and raises the price target from $132 to $150.
Vistagen Announces The Two Leading Proxy Advisory Firms, Institutional Shareholder Services And Glass Lewis, Recommend Stockholders Vote “For” Proposal No. 5 To Provide Its Board With The Option To Implement A Future Reverse Stock Split, If Necessary
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) (the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central